[Myelodysplastic syndromes].
D002869:Chromosome Aberrations; D003561:Cytarabine / Q000627:therapeutic use; D006801:Humans; D007938:Leukemia / Q000209:etiology; D009190:Myelodysplastic Syndromes / Q000145:classification / Q000188:drug therapy / Q000235:genetics; D011379:Prognosis
D003561:Cytarabine
Síndromes mielodisplásicos.